These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 29084790)

  • 1. Targeted Adherence Intervention to Reach Glycemic Control with Insulin Therapy for patients with Diabetes (TARGIT-Diabetes): rationale and design of a pragmatic randomised clinical trial.
    Lewey J; Wei W; Lauffenburger JC; Makanji S; Chant A; DiGeronimo J; Nanchanatt G; Jan S; Choudhry NK
    BMJ Open; 2017 Oct; 7(10):e016551. PubMed ID: 29084790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of Targeted Insulin-Adherence Interventions for Glycemic Control Using Predictive Analytics Among Patients With Type 2 Diabetes: A Randomized Clinical Trial.
    Lauffenburger JC; Lewey J; Jan S; Makanji S; Ferro CA; Krumme AA; Lee J; Ghazinouri R; Haff N; Choudhry NK
    JAMA Netw Open; 2019 Mar; 2(3):e190657. PubMed ID: 30874782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized controlled trial of clinical pharmacy management of patients with type 2 diabetes in an outpatient diabetes clinic in Jordan.
    Jarab AS; Alqudah SG; Mukattash TL; Shattat G; Al-Qirim T
    J Manag Care Pharm; 2012 Sep; 18(7):516-26. PubMed ID: 22971205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of Glycemic Control of a Pharmacist-Led Medication Management Program in Patients with Type 2 Diabetes.
    Ko JJ; Lu J; Rascati K; Stock EM; Juan J; Suh K; Kim Y; Tabor PA; Godley PJ
    J Manag Care Spec Pharm; 2016 Jan; 22(1):32-7. PubMed ID: 27015049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Medicines Advice Service Evaluation (MASE): a randomised controlled trial of a pharmacist-led telephone based intervention designed to improve medication adherence.
    Lyons I; Barber N; Raynor DK; Wei L
    BMJ Qual Saf; 2016 Oct; 25(10):759-69. PubMed ID: 26755665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted and tailored pharmacist-led intervention to improve adherence to antihypertensive drugs among patients with type 2 diabetes in Indonesia: study protocol of a cluster randomised controlled trial.
    Alfian SD; Abdulah R; Denig P; van Boven JFM; Hak E
    BMJ Open; 2020 Jan; 10(1):e034507. PubMed ID: 31911526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of pharmaceutical care interventions on glycemic control and other health-related clinical outcomes in patients with type 2 diabetes: Randomized controlled trial.
    Wishah RA; Al-Khawaldeh OA; Albsoul AM
    Diabetes Metab Syndr; 2015; 9(4):271-6. PubMed ID: 25301007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and rationale of the Cardiovascular Health and Text Messaging (CHAT) Study and the CHAT-Diabetes Mellitus (CHAT-DM) Study: two randomised controlled trials of text messaging to improve secondary prevention for coronary heart disease and diabetes.
    Huo X; Spatz ES; Ding Q; Horak P; Zheng X; Masters C; Zhang H; Irwin ML; Yan X; Guan W; Li J; Li X; Spertus JA; Masoudi FA; Krumholz HM; Jiang L
    BMJ Open; 2017 Dec; 7(12):e018302. PubMed ID: 29273661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of a novel pharmacist-delivered behavioral intervention for patients with poorly-controlled diabetes: The ENhancing outcomes through Goal Assessment and Generating Engagement in Diabetes Mellitus (ENGAGE-DM) pragmatic randomized trial.
    Lauffenburger JC; Ghazinouri R; Jan S; Makanji S; Ferro CA; Lewey J; Wittbrodt E; Lee J; Haff N; Fontanet CP; Choudhry NK
    PLoS One; 2019; 14(4):e0214754. PubMed ID: 30939143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale and design of the ENhancing outcomes through Goal Assessment and Generating Engagement in Diabetes Mellitus (ENGAGE-DM) pragmatic trial.
    Lauffenburger JC; Lewey J; Jan S; Nanchanatt G; Makanji S; Ferro CA; Sheehan J; Wittbrodt E; Morawski K; Lee J; Ghazinouri R; Choudhry NK
    Contemp Clin Trials; 2017 Aug; 59():57-63. PubMed ID: 28571997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a Pharmacist-Managed Diabetes Program in a Primary Care Setting Within an Integrated Health Care System.
    Benedict AW; Spence MM; Sie JL; Chin HA; Ngo CD; Salmingo JF; Vidaurreta AT; Rashid N
    J Manag Care Spec Pharm; 2018 Feb; 24(2):114-122. PubMed ID: 29384029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study investigating the impact of pharmacist involvement on the outcomes of diabetes medication therapy adherence program Malaysia.
    Lim PC; Lim K; Embee ZC; Hassali MA; Thiagarajan A; Khan TM
    Pak J Pharm Sci; 2016 Mar; 29(2):595-601. PubMed ID: 27087103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a Remotely Delivered Tailored Multicomponent Approach to Enhance Medication Taking for Patients With Hyperlipidemia, Hypertension, and Diabetes: The STIC2IT Cluster Randomized Clinical Trial.
    Choudhry NK; Isaac T; Lauffenburger JC; Gopalakrishnan C; Lee M; Vachon A; Iliadis TL; Hollands W; Elman S; Kraft JM; Naseem S; Doheny S; Lee J; Barberio J; Patel L; Khan NF; Gagne JJ; Jackevicius CA; Fischer MA; Solomon DH; Sequist TD
    JAMA Intern Med; 2018 Sep; 178(9):1182-1189. PubMed ID: 30083727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caring for poorly controlled diabetes mellitus: a randomized pharmacist intervention.
    Odegard PS; Goo A; Hummel J; Williams KL; Gray SL
    Ann Pharmacother; 2005 Mar; 39(3):433-40. PubMed ID: 15701763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medication Management Program: Adherence, Disease-related Knowledge, Health-related Quality of Life, and Glycemic Control for Type 2 Diabetes Mellitus.
    Nazir SUR; Hassali MA; Saleem F; Haque N
    Altern Ther Health Med; 2020 Jul; 26(S2):4-10. PubMed ID: 31634877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycemic control and preventive care measures of indigent diabetes patients within a pharmacist-managed insulin titration program vs standard care.
    Salvo MC; Brooks AM
    Ann Pharmacother; 2012 Jan; 46(1):29-34. PubMed ID: 22202497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. REinforcement learning to improve non-adherence for diabetes treatments by Optimising Response and Customising Engagement (REINFORCE): study protocol of a pragmatic randomised trial.
    Lauffenburger JC; Yom-Tov E; Keller PA; McDonnell ME; Bessette LG; Fontanet CP; Sears ES; Kim E; Hanken K; Buckley JJ; Barlev RA; Haff N; Choudhry NK
    BMJ Open; 2021 Dec; 11(12):e052091. PubMed ID: 34862289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicomponent provider-patient intervention to improve glycaemic control in Medicaid-insured pregnant individuals with type 2 diabetes: clinical trial protocol for the ACHIEVE study.
    Venkatesh KK; Joseph JJ; Swoboda C; Strouse R; Hoseus J; Baker C; Summerfield T; Bartholomew A; Buccilla L; Pan X; Sieck C; McAlearney AS; Huerta TR; Fareed N
    BMJ Open; 2023 May; 13(5):e074657. PubMed ID: 37164461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a Pharmacist-Led Program on Improving Outcomes in Patients with Type 2 Diabetes Mellitus from Northern Cyprus: A Randomized Controlled Trial.
    Korcegez EI; Sancar M; Demirkan K
    J Manag Care Spec Pharm; 2017 May; 23(5):573-582. PubMed ID: 28448779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.